> top > docs > PubMed:23667615 > annotations

PubMed:23667615 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-130 Sentence denotes Inhaled steroids modulate extracellular matrix composition in bronchial biopsies of COPD patients: a randomized, controlled trial.
T2 131-141 Sentence denotes RATIONALE:
T3 142-294 Sentence denotes Smoking and inflammation contribute to the pathogenesis of chronic obstructive pulmonary disease (COPD), which involves changes in extracellular matrix.
T4 295-370 Sentence denotes This is thought to contribute to airway remodeling and airflow obstruction.
T5 371-566 Sentence denotes We have previously observed that long-term treatment with inhaled corticosteroids can not only reduce bronchial inflammation, but can also attenuate lung function decline in moderate-severe COPD.
T6 567-691 Sentence denotes We hypothesized that inhaled corticosteroids and current smoking modulate bronchial extracellular matrix components in COPD.
T7 692-702 Sentence denotes OBJECTIVE:
T8 703-958 Sentence denotes To compare major extracellular matrix components (elastic fibers; proteoglycans [versican, decorin]; collagens type I and III) in bronchial biopsies 1) after 30-months inhaled steroids treatment or placebo; and 2) between current and ex-smokers with COPD.
T9 959-967 Sentence denotes METHODS:
T10 968-1215 Sentence denotes We included 64 moderate-severe, steroid-naive COPD patients (24/40 (ex)-smokers, 62±7 years, 46 (31-54) packyears, post-bronchodilator forced expiratory volume in one second (FEV1) 62±9% predicted) at baseline in this randomized, controlled trial.
T11 1216-1306 Sentence denotes 19 and 13 patients received 30-months treatment with fluticasone or placebo, respectively.
T12 1307-1451 Sentence denotes Bronchial biopsies collected at baseline and after 30 months were studied using (immuno)histochemistry to evaluate extracellular matrix content.
T13 1452-1533 Sentence denotes Percentage and density of stained area were calculated by digital image analysis.
T14 1534-1542 Sentence denotes RESULTS:
T15 1543-1728 Sentence denotes 30-Months inhaled steroids increased the percentage stained area of versican (9.6% [CI 0.9 to 18.3%]; p = 0.03) and collagen III (20.6% [CI 3.8 to 37.4%]; p = 0.02) compared to placebo.
T16 1729-1873 Sentence denotes Increased collagen I staining density correlated with increased post-bronchodilator FEV1 after inhaled steroids treatment (Rs = 0.45, p = 0.04).
T17 1874-2008 Sentence denotes There were no differences between smokers and ex-smokers with COPD in percentages and densities for all extracellular matrix proteins.
T18 2009-2021 Sentence denotes CONCLUSIONS:
T19 2022-2169 Sentence denotes These data show that long-term inhaled corticosteroids treatment partially changes the composition of extracellular matrix in moderate-severe COPD.
T20 2170-2344 Sentence denotes This is associated with increased lung function, suggesting that long-term inhaled steroids modulate airway remodeling thereby potentially preventing airway collapse in COPD.
T21 2345-2423 Sentence denotes Smoking status is not associated with bronchial extracellular matrix proteins.
T22 2424-2443 Sentence denotes TRIAL REGISTRATION:
T23 2444-2475 Sentence denotes ClinicalTrials.gov NCT00158847.
T1 0-130 Sentence denotes Inhaled steroids modulate extracellular matrix composition in bronchial biopsies of COPD patients: a randomized, controlled trial.
T2 131-141 Sentence denotes RATIONALE:
T3 142-294 Sentence denotes Smoking and inflammation contribute to the pathogenesis of chronic obstructive pulmonary disease (COPD), which involves changes in extracellular matrix.
T4 295-370 Sentence denotes This is thought to contribute to airway remodeling and airflow obstruction.
T5 371-566 Sentence denotes We have previously observed that long-term treatment with inhaled corticosteroids can not only reduce bronchial inflammation, but can also attenuate lung function decline in moderate-severe COPD.
T6 567-691 Sentence denotes We hypothesized that inhaled corticosteroids and current smoking modulate bronchial extracellular matrix components in COPD.
T7 692-702 Sentence denotes OBJECTIVE:
T8 703-958 Sentence denotes To compare major extracellular matrix components (elastic fibers; proteoglycans [versican, decorin]; collagens type I and III) in bronchial biopsies 1) after 30-months inhaled steroids treatment or placebo; and 2) between current and ex-smokers with COPD.
T9 959-967 Sentence denotes METHODS:
T10 968-1215 Sentence denotes We included 64 moderate-severe, steroid-naive COPD patients (24/40 (ex)-smokers, 62±7 years, 46 (31-54) packyears, post-bronchodilator forced expiratory volume in one second (FEV1) 62±9% predicted) at baseline in this randomized, controlled trial.
T11 1216-1306 Sentence denotes 19 and 13 patients received 30-months treatment with fluticasone or placebo, respectively.
T12 1307-1451 Sentence denotes Bronchial biopsies collected at baseline and after 30 months were studied using (immuno)histochemistry to evaluate extracellular matrix content.
T13 1452-1533 Sentence denotes Percentage and density of stained area were calculated by digital image analysis.
T14 1534-1542 Sentence denotes RESULTS:
T15 1543-1728 Sentence denotes 30-Months inhaled steroids increased the percentage stained area of versican (9.6% [CI 0.9 to 18.3%]; p = 0.03) and collagen III (20.6% [CI 3.8 to 37.4%]; p = 0.02) compared to placebo.
T16 1729-1873 Sentence denotes Increased collagen I staining density correlated with increased post-bronchodilator FEV1 after inhaled steroids treatment (Rs = 0.45, p = 0.04).
T17 1874-2008 Sentence denotes There were no differences between smokers and ex-smokers with COPD in percentages and densities for all extracellular matrix proteins.
T18 2009-2021 Sentence denotes CONCLUSIONS:
T19 2022-2169 Sentence denotes These data show that long-term inhaled corticosteroids treatment partially changes the composition of extracellular matrix in moderate-severe COPD.
T20 2170-2344 Sentence denotes This is associated with increased lung function, suggesting that long-term inhaled steroids modulate airway remodeling thereby potentially preventing airway collapse in COPD.
T21 2345-2423 Sentence denotes Smoking status is not associated with bronchial extracellular matrix proteins.
T22 2424-2443 Sentence denotes TRIAL REGISTRATION:
T23 2444-2475 Sentence denotes ClinicalTrials.gov NCT00158847.

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 201-238 HP_0006510 denotes chronic obstructive pulmonary disease

Allie

Id Subject Object Predicate Lexical cue
SS1_23667615_2_0 201-238 expanded denotes chronic obstructive pulmonary disease
SS2_23667615_2_0 240-244 abbr denotes COPD
AE1_23667615_2_0 SS1_23667615_2_0 SS2_23667615_2_0 abbreviatedTo chronic obstructive pulmonary disease,COPD

Zierdiyeerkenaili_800_3

Id Subject Object Predicate Lexical cue
T1 240-244 DP denotes COPD
T2 84-88 DP denotes COPD
T3 561-565 DP denotes COPD
T4 686-690 DP denotes COPD
T5 953-957 DP denotes COPD
T6 1014-1018 DP denotes COPD
T7 1936-1940 DP denotes COPD
T8 2164-2168 DP denotes COPD
T9 2339-2343 DP denotes COPD
T10 201-238 DP denotes chronic obstructive pulmonary disease
T11 901-908 CI denotes placebo
T12 1284-1291 CI denotes placebo
T13 1720-1727 CI denotes placebo
T14 879-887 CI denotes steroids
T15 8-16 CI denotes steroids
T16 1561-1569 CI denotes steroids
T17 1832-1840 CI denotes steroids
T18 2253-2261 CI denotes steroids

yaoziqian_800_3

Id Subject Object Predicate Lexical cue
T1 8-16 CI denotes steroids
T2 879-887 CI denotes steroids
T3 1561-1569 CI denotes steroids
T4 1832-1840 CI denotes steroids
T5 2253-2261 CI denotes steroids
T6 84-88 DP denotes COPD
T7 240-244 DP denotes COPD
T8 561-565 DP denotes COPD
T9 686-690 DP denotes COPD
T10 953-957 DP denotes COPD
T11 1014-1018 DP denotes COPD
T12 1936-1940 DP denotes COPD
T13 2164-2168 DP denotes COPD
T14 2339-2343 DP denotes COPD
T15 201-238 DP denotes chronic obstructive pulmonary disease
T16 1720-1727 CI denotes placebo
T17 901-908 CI denotes placebo
T18 1284-1291 CI denotes placebo